Rush University Cancer Center

Chicago, Illinois 60612

0 studies enrolling now · 12 studies all time

What they study most

Abnormal DNA Repair, Acute Myeloid Leukemia, Advanced Cutaneous Melanoma, Breast Cancer, Glioblastoma Multiforme, Adult, Leukemia, Myeloid, Acute, Lymphoma, Metastatic Prostate Carcinoma, Myelodysplastic Syndromes, Pancreatic Cancer, Primary Myelofibrosis, Prostate Cancer

Studies at this site

• Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source — Recruiting now
• Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects — Running, not enrolling
• A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme — Running, not enrolling
• Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 — Running, not enrolling
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Completed
• Connect® Myeloid Disease Registry — Stopped early
• Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC — Stopped early
• BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007 — Completed
• ITIL-168 in Advanced Melanoma — Stopped early
• Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma — Completed
• Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors. — Status unconfirmed
• Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer — Completed